Application of newly developed DPP4 inhibitors revealed several physiological and pathological processes such as lipid metabolism, myocardial, renal and liver functions, atherosclerosis and inflammation in which DPP4 is involved10,11. This evidence concerns the gene DPP4 and atherosclerosis.